Literature DB >> 29966655

Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis.

Huiqin Hu1, Li Yang2, Lijun Li3, Changchun Zeng4.   

Abstract

The underlying functions of long non-coding RNAs (lncRNAs) on chemoresistance in multiple cancers have been testified. However, the function and mechanism of lncRNAs on chemoresistance in hepatocellular carcinoma are still confused. In this study, we concentrated on the function and mechanism of KCNQ1OT1 on oxaliplatin resistance in hepatocellular carcinoma. Results showed that KCNQ1OT1 was significantly up-regulated in oxaliplatin-resistant HepG2 and Huh7 cells. Moreover, knockdown of KCNQ1OT1 inhibited the cell proliferation, migration, invasion and reduced the expression of drug-resistant gene (MRP5, MDR1, LRP1). Additionally, bioinformatics analysis and dual-luciferase reporter assay showed that miR-7-5p directly targeted the 3'-UTR of miR-7-5p and ABCC1 mRNA, indicating that KCNQ1OT1 regulated the expression of ABCC1 via endogenous sponging miR-7-5p. Conclusively, KCNQ1OT1 modulated oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis, indicating a novel approach for the treatment of hepatocellular carcinoma.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCC1; Hepatocellular carcinoma; KCNQ1OT1; Oxaliplatin resistant; miR-7-5p

Mesh:

Substances:

Year:  2018        PMID: 29966655     DOI: 10.1016/j.bbrc.2018.06.168

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.

Authors:  Wei Wang; Shuai Han; Wei Gao; Yuan Feng; Kunhang Li; Di Wu
Journal:  Cell Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.046

2.  ABCC6P1 pseudogene induces ABCC6 upregulation and multidrug resistance in breast cancer.

Authors:  Mahnaz Hashemi; Masoud Golalipour
Journal:  Mol Biol Rep       Date:  2022-08-28       Impact factor: 2.742

Review 3.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

Review 4.  Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.

Authors:  Sen Han; Ting Zhang; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul; Zhihong Yang
Journal:  J Investig Med       Date:  2020-08-24       Impact factor: 3.235

5.  Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7.

Authors:  Yisheng Gao; Jie Liu; Jing Huan; Fengyuan Che
Journal:  Cancer Cell Int       Date:  2020-07-22       Impact factor: 5.722

6.  LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.

Authors:  Di Xian; Yu Zhao
Journal:  J Cell Mol Med       Date:  2019-04-17       Impact factor: 5.310

Review 7.  The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.

Authors:  Man Wang; Fei Yu; Xinzhe Chen; Peifeng Li; Kun Wang
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-15       Impact factor: 8.886

8.  Long Noncoding RNA KCNQ1OT1 Promotes the Progression of Non-Small Cell Lung Cancer via Regulating miR-204-5p/ATG3 Axis.

Authors:  Yan Kang; Yaoli Jia; Qilong Wang; Qianru Zhao; Meng Song; Ran Ni; Jing Wang
Journal:  Onco Targets Ther       Date:  2019-12-10       Impact factor: 4.147

9.  KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis.

Authors:  Yaru Zhu; Yefeng Shen; Rui Chen; Hui Li; Yuanzhou Wu; Fuwei Zhang; Weimei Huang; Linlang Guo; Qunqing Chen; Huanxin Liu
Journal:  Ann Transl Med       Date:  2021-05

10.  Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects.

Authors:  Xinrong Lin; Xiaosong Xiang; Bing Feng; Hao Zhou; Ting Wang; Xiaoyuan Chu; Rui Wang
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.